Thursday, April, 18, 2019 08:44:51
Page125.org
Menu
  • Medical Devices
  • Biotechnology
  • Healthcare IT
  • Pharmaceuticals
Trending News:
  • FDA prohibits Coloplast, Boston Scientific from selling surgical mesh
  • MediciNova plans to move ahead with phase-3 trial of MN-166 in ALS
  • Dr. Reddy’s Laboratories acquires 42 ANDAs portfolio in the U.S.
  • Catalent Inc to acquire Paragon Bioservices in a $1.2 billion deal
Home
Contact US

Contact US

Physical Address

We are moving...
We will update our new address soon.
e-Mail: [email protected]

Contact for News

Ojaswita Kutepatil[email protected] https://twitter.com/ojaswita_k
Shikha Sinha[email protected] https://twitter.com/shikhas999/
Editor[email protected]

Latest News

FDA prohibits Coloplast, Boston Scientific from selling surgical mesh

FDA prohibits Coloplast, Boston Scientific from selling surgical mesh

MediciNova plans to move ahead with phase-3 trial of MN-166 in ALS

MediciNova plans to move ahead with phase-3 trial of MN-166 in ALS

Dr. Reddy's Laboratories acquires 42 ANDAs portfolio in the U.S.

Dr. Reddy’s Laboratories acquires 42 ANDAs portfolio in the U.S.

Catalent Inc to acquire Paragon Bioservices in a $1.2 billion deal

Catalent Inc to acquire Paragon Bioservices in a $1.2 billion deal

Cerner and naviHealth to add a new offering to BPCI Advanced program

Cerner and naviHealth to add a new offering to BPCI Advanced program

AstraZeneca & MSD Inc win EU approval for breast-cancer drug Lynparza

AstraZeneca & MSD Inc win EU approval for breast-cancer drug Lynparza

  • About Us
  • Privacy Policy
  • Editorial Policy
  • Our Team
  • Contact US

Physical Address

We are moving...
We will update our new address soon.
e-Mail: [email protected]
Page125.org Copyright © 2019.